| Print
MERCK KGAA O.N. (MRK)
AKTIEN O.N.Not yet a customer?
Low cost dealing from £1.50Choose from our range of SIPP, ISA and Dealing accounts
Find out moreThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
Address
DEU
Telephone
+49 6151729591
Forecast key dates
| Name | Key Date |
|---|---|
| Merck KGaA Second Quarter Earnings Conference Call for 2026 | 2026-08-06T09:30:00 |
| Merck KGaA Second Quarter Earnings Results for 2026 | 2026-08-06T07:00:00 |
| Merck KGaA First Quarter Earnings Conference Call for 2026 | 2026-05-13T09:30:00 |
| Merck KGaA First Quarter Earnings Results for 2026 | 2026-05-13T07:00:00 |
| Merck KGaA Annual General Meeting for 2026 | 2026-04-24T10:00:00 |
| Merck KGaA Fourth Quarter Earnings Conference Call for 2025 | 2026-03-05T10:00:00 |
| Merck KGaA Fourth Quarter Earnings Results for 2025 | 2026-03-05T07:00:00 |
| Merck KGaA Annual Report for 2025 | 2026-02-18T00:00:00 |
| Merck KGaA Third Quarter Earnings Conference Call for 2025 | 2025-11-13T14:00:00 |
| Merck KGaA Third Quarter Earnings Results for 2025 | 2025-11-13T07:00:00 |
| Merck Capital Markets Day 2025 | 2025-10-16T09:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Merck Capital Markets Day 2025 | 2025-10-16T09:00:00 |
| Merck KGaA Second Quarter Earnings Conference Call for 2025 | 2025-08-07T14:00:00 |
| Merck KGaA Second Quarter Earnings Results for 2025 | 2025-08-07T07:00:00 |
| Merck KGaA First Quarter Earnings Conference Call for 2025 | 2025-05-15T09:30:00 |
| Merck KGaA First Quarter Earnings Results for 2025 | 2025-05-15T07:00:00 |
| Merck KGaA Annual General Meeting for 2025 | 2025-04-25T10:00:00 |
| Merck KGaA Fourth Quarter Earnings Conference Call for 2024 | 2025-03-06T14:00:00 |
| Merck KGaA Fourth Quarter Earnings Results for 2024 | 2025-03-06T07:00:00 |
| Merck KGaA Annual Report for 2024 | 2025-02-18T00:00:00 |
| Merck KGaA Third Quarter Earnings Conference Call for 2024 | 2024-11-14T09:30:00 |
| Merck KGaA Third Quarter Earnings Results for 2024 | 2024-11-14T07:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.